← Evidence map

Observational studyArthritis research & therapy2016

Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis.

Jérémie Sellam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

17 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this paperpooled ittrialcites it

The trial

NCT01126541phase 3224 enrolled2006
Full record →Abstract, authors, funding and every citing paper · PMID 27964756